Latest Weight: Misc. news
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
posted May 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills
posted May 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
First Weight-Loss Pill From Lilly Shows Promising Results
posted April 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pfizer Ends Testing of Obesity Pill After Possible Liver Injury
posted April 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Bariatric Surgery Is Effective Rescue Strategy After GLP-1 Receptor Agonist Failure 
Weight-Loss Surgery Produces Lasting Diabetes Remission 
Obesity Linked to Early-Onset Cancer Risk in Young Adults 
2018 to 2025 Saw Sharp Rise in Postpartum GLP-1 Receptor Agonist Use Related Articles
Mom"s Poor Sleep in Late Pregnancy Linked to Offspring"s Obesity Risk in Early Childhood .jpg)
Time-Restricted Eating May Help Patients With Type 1 Diabetes 
Calorie Restriction and Mediterranean-Style Diet Yield Similar Weight Loss 
Model May Help Identify Women at Risk for Overactive Bladder Monthly Specialist Briefings
Stay Connected
